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To the Editor:
We read, with interest, the article 
“Resection of a Solitary Pulmonary 
Metastasis from Prostatic Adeno-
carcinoma Misdiagnosed as a Bron-
chocele: Usefulness of 18F-Choline 
and 18F-FDG PET/CT” by Calais 
et al.1. We agree entirely that there is a 
valuable learning point from this case 
and would like to share a recent case 
from our institution to reinforce this 
lesson.
An 84-year-old female patient 
with a previous colorectal mucinous 
adenocarcinoma, treated with surgi-
cal resection, presented with a cough. 
Subsequent chest radiograph (CXR) 
and computer tomography (CT) scan 
conﬁrmed the presence of a lobulated 
and elongated lesion (ﬁnger in glove 
sign) in the right middle lobe con-
sistent with a bronchocele (Fig. 1). 
The patient went on to have an 
18-F-fluorodeoxyglucose (FDG) pos-
itron emission computed tomography 
(PET)-CT scan, which demonstrated 
no FDG uptake within the lesion, 
again consistent with a bronchocele 
(Fig. 2). Bronchoscopy demonstrated 
an intraluminal obstruction of the 
right middle lobe by solid, green-
yellow tissue. The tissue could not 
be cleared with suction or by appli-
cation of saline. Endobronchial biop-
sies yielded large clumps of tissue 
and, to our surprise, histopathologi-
cal analysis revealed mucin-secreting 
tumor cells. The tumor demonstrated 
strong immunopositivity for CK20 
and CDX2, compatible with a diagno-
sis of metastatic mucinous colorectal 
adenocarcinoma. The patient went on 
to have a right middle lobectomy. The 
histology from the primary colorec-
tal tumor was reviewed and found to 
be morphologically and immunohis-
tochemically similar to the resected 
lung lesion.
In both cases, it would be 
understandable to take reassurance 
from the radiological appearances of 
these two benign-appearing but ulti-
mately malignant solitary metastatic 
deposits. Both were thought be a 
bronchocele because of their radio-
logical appearance. Furthermore, 
in our case, the lesion in question 
showed no FDG uptake, again in 
favor of the radiological hypothesis 
of a benign bronchocele. However, in 
the context of mucinous carcinomas, 
we must be careful with the inter-
pretation of FDG avidity, which has 
a high false-negative rate2; an unsur-
prising fact given that FDG avidity is 
negatively correlated with degree of 
mucin within a tumor.3
We also recognize that this is as 
an unusual presentation of pulmonary 
metastases from colorectal carcinoma. 
The common clinical-radiological sce-
nario is parenchymal nodules. Both 
endobronchial metastases and a 
“pseudo-bronchocele” are much less 
frequently encountered.4,5
The 18F-choline PET-CT 
described in the report by Calais et 
al. is not a test we are familiar with in 
the United Kingdom. The biochemi-
cal mechanisms utilized by this test, 
described elegantly by the authors, 
could overcome the problems of 
FDG PET-CT in cases such as lep-
idic adenocarcinoma of the lung. 
We would like to ask the authors if 
this technique could add value to 
the assessment of possible mucinous 
tumors and if they see a future role 
for 18F-choline PET-CT in the man-
agement of lung cancer.
In summary, we would advocate a 
high index of suspicion of malignancy 
in pulmonary lesions thought to be a 
bronchocele radiologically, where there 
is history or risk factors for a mucinous 
carcinoma.
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FIGURE 1. Computed tomography of the thorax demonstrating an intraluminal, elongated opacity in the lateral segment of 
the right middle lobe.
FIGURE 2. 18-F-Fluorodeoxyglucose (FDG) positron emission tomography-computed tomography demonstrating no FDG uptake 
within the right middle lobe lesion.
